Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms
This study is ongoing, but not recruiting participants.
First Received: April 21, 2006   Last Updated: August 30, 2006   History of Changes
Sponsors and Collaborators: University of Michigan
NeilMed Pharmaceuticals
Information provided by: University of Michigan
ClinicalTrials.gov Identifier: NCT00318006
  Purpose

This study will compare nasal saline irrigation with nasal saline spray for the treatment of chronic nasal and sinus symptoms. Participants will complete a questionnaire regarding their nasal and sinus symptoms and will be randomly assigned to one of the treatment groups. Each participant will be instructed on how to perform daily nasal treatment.The subjects will complete follow-up surveys at regular intervals to assess any change in their nasal symptoms after starting nasal saline treatment. Participants may take their usual medications for sinus symptoms during their participation in the study.


Condition Intervention Phase
Chronic Rhinosinusitis
Procedure: saline irrigation
Procedure: saline spray
Phase IV

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Uncontrolled, Parallel Assignment
Official Title: A Randomized Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Change in the mean score of the sinonasal outcome test-20
  • Change in medication usage for nasal and sinus symptoms

Estimated Enrollment: 150
Study Start Date: December 2005
Estimated Study Completion Date: August 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age > 18 years
  • Presence of any one of the following symptoms for > 4 days/week and > 15 days in the past 1 month:

    • Nasal stuffiness
    • Nasal congestion
    • Nasal dryness or crusting
    • Abnormal nasal discharge
    • Thick nasal discharge

Exclusion Criteria:

  • Functional endoscopic sinus surgery (FESS) in the last 3 months
  • Epistaxis in the last 3 months that required treatment
  • Acute illness like otitis media, laryngitis, pharyngitis, or rhinitis in the last 2 weeks
  • Acute attack of asthma or bronchitis in the last 2 weeks
  • Inability to speak or read English
  • Current use of any of the study medications regularly for more than a week in the last 1 month
  • Any history of intolerance to saline treatment (if used)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00318006

Locations
United States, Michigan
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
NeilMed Pharmaceuticals
Investigators
Principal Investigator: Melissa A Pynnonen, MD University of Michigan
  More Information

Additional Information:
No publications provided by University of Michigan

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Study ID Numbers: HUM00000253
Study First Received: April 21, 2006
Last Updated: August 30, 2006
ClinicalTrials.gov Identifier: NCT00318006     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
chronic
nasal
sinus
symptoms

Study placed in the following topic categories:
Pseudoephedrine
Neurotransmitter Agents
Adrenergic Agents
Anti-Asthmatic Agents
Central Nervous System Stimulants
Cardiovascular Agents
Nasal Decongestants
Oxymetazoline
Phenylephrine
Vasoconstrictor Agents
Ephedrine
Peripheral Nervous System Agents
Bronchodilator Agents

Additional relevant MeSH terms:
Pseudoephedrine
Respiratory System Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Sympathomimetics
Physiological Effects of Drugs
Anti-Asthmatic Agents
Central Nervous System Stimulants
Cardiovascular Agents
Pharmacologic Actions
Nasal Decongestants
Autonomic Agents
Therapeutic Uses
Vasoconstrictor Agents
Ephedrine
Peripheral Nervous System Agents
Bronchodilator Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on July 02, 2009